Google
×
Any time
  • Any time
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
Verbatim
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and ...
Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow ...
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow ...
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy - European Blood and Marrow ...
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow ...
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow ...
... Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group. April 2008; Journal of Clinical Oncology 26(9): ...
... Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group ... Mucositis in Patients Receiving High-Dose ...
(2008) Prospective oral mucositis audit : oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy : european blood and marrow ...
Jan 1, 2009 · ... high-dose chemotherapy, medical resource use, STEM-CELL TRANSPLANTATION, MARROW-TRANSPLANTATION, ECONOMIC OUTCOMES, RISK-FACTORS, BLOOD ...